Pediatric Study Waiver, Deferral Determinations Could Harm Approvals, Firms Tell FDA

Comments on draft guidance say agency’s belated decisions on requests for waivers or deferrals of pediatric studies could lead to “refuse to file” determinations; FDA has missed statutory deadline to promulgate regulations on pediatric study plans.